Erik Buntinx
Impact in
-
- Tryptophan and brain disorders
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
Papers in
-
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 2
-
- Receptor Mechanisms and Signaling 3
- Pharmacological Receptor Mechanisms and Effects 2
- Co-authors
- Thomas E. Schläepfer (3 shared papers)Htay Htay Han (2 shared papers)Donna M. Ambrosino (1 shared paper)Kurt Audenaert (3 shared papers)Edison Alberto (2 shared papers)Alan Wade (1 shared paper)Maya Hites (1 shared paper)Kathelijne Peremans (2 shared papers)
- Journals
- Vaccine (2 papers)European Neuropsychopharmacology (2 papers)Human Vaccines & Immunotherapeutics (1 paper)European Psychiatry (1 paper)Nuclear Medicine Communications (1 paper)
- Partner nations
- BelgiumUnited StatesNetherlands
In The Last Decade
Erik Buntinx
10 papers receiving 42 citations
Peers
Comparison fields: 5 of 33
- Biological Psychiatry 3
- Infectious Diseases 15
- Pharmacology 11
- Small Animals 4
- Anesthesiology and Pain Medicine 3
Countries citing papers authored by Erik Buntinx
This map shows the geographic impact of Erik Buntinx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Buntinx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Buntinx more than expected).
Fields of papers citing papers by Erik Buntinx
This network shows the impact of papers produced by Erik Buntinx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Buntinx. The network helps show where Erik Buntinx may publish in the future.
Co-authors
The 25 scholars most cited alongside Erik Buntinx, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 10 | |
| 2 | 2008 | 10 | |
| 3 | 2023 | 10 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 4 | |
| 6 | 2010 | 2 | |
| 7 | 2025 | 1 | |
| 8 | Preclinical and clinical evidence for the efficacy of pipamperone in augmenting the antidepressant effects of the SSRI citalopram | 2008 | 1 |
| 9 | 2011 | 1 | |
| 10 | 2008 | 1 |
About Erik Buntinx
Erik Buntinx is a scholar working on Infectious Diseases, Molecular Biology, Pharmacology, Cellular and Molecular Neuroscience and Epidemiology, having authored 10 papers that have together received 44 indexed citations. Recurring topics across this work include Treatment of Major Depression (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Receptor Mechanisms and Signaling (3 papers), COVID-19 Clinical Research Studies (2 papers), Neurotransmitter Receptor Influence on Behavior (2 papers), Pharmacological Receptor Mechanisms and Effects (2 papers), Vaccine Coverage and Hesitancy (1 paper) and Bipolar Disorder and Treatment (1 paper). The work is most often cited by research in Biological Psychiatry (3 citations), Infectious Diseases (15 citations), Pharmacology (11 citations), Small Animals (4 citations) and Anesthesiology and Pain Medicine (3 citations). Erik Buntinx has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Thomas E. Schläepfer, Htay Htay Han, Donna M. Ambrosino, Kurt Audenaert, Edison Alberto, Alan Wade, Maya Hites, Kathelijne Peremans, Charles B. Nemeroff and Ralf Clemens. Their work appears in journals such as Vaccine, European Neuropsychopharmacology, Human Vaccines & Immunotherapeutics, European Psychiatry and Nuclear Medicine Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.